The β


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 09 06 2024
accepted: 11 09 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: epublish

Résumé

Adrenergic receptors regulate metabolic, cardiovascular, and immunological functions in response to the sympathetic nervous system. The effect of β The effects of nebivolol were tested on healthy human peripheral blood mononuclear cells, purified memory Th cells, and polarized naive Th17 cells activated with anti-CD3/anti-CD28/anti-CD2 ImmunoCult reagent. IFN-γ, IL-4, and IL-17A, which are primarily derived from Th1, Th2, and Th17 cells, respectively, were quantified by ELISA and flow cytometry. IL-10 was measured by ELISA. Gene expression of RORC, ADRB1, ADRB2, and ADRB3 was evaluated by qPCR. The ADRB2 gene was knocked out in memory Th cells using CRISPR/Cas9. Protein expression of phosphorylated serine133-CREB and phosphorylated NF-κB p65 was assessed by Western blot. Proliferation was assessed by fluorescent dye loading and flow cytometry. Nebivolol treatment decreased IL-17A and IFN-γ secretion by activated memory Th cells and elevated IL-4 levels. Nebivolol reduced the proportion of IL-17A The findings demonstrate that nebivolol acts through a β

Identifiants

pubmed: 39445009
doi: 10.3389/fimmu.2024.1446424
pmc: PMC11496295
doi:

Substances chimiques

Nebivolol 030Y90569U
Adrenergic beta-2 Receptor Agonists 0
NF-kappa B 0
Receptors, Adrenergic, beta-2 0
Interleukin-17 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1446424

Informations de copyright

Copyright © 2024 Hajiaghayi, Gholizadeh, Han, Little, Rahbari, Ardila, Lopez Naranjo, Tehranimeh, Shih and Darlington.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Mehri Hajiaghayi (M)

Department of Biology, Concordia University, Montréal, QC, Canada.

Fatemeh Gholizadeh (F)

Department of Biology, Concordia University, Montréal, QC, Canada.

Eric Han (E)

Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada.

Samuel R Little (SR)

Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada.

Niloufar Rahbari (N)

Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada.

Isabella Ardila (I)

Department of Biology, Concordia University, Montréal, QC, Canada.

Carolina Lopez Naranjo (C)

Department of Biology, Concordia University, Montréal, QC, Canada.

Kasra Tehranimeh (K)

Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada.

Steve C C Shih (SCC)

Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada.

Peter J Darlington (PJ)

Department of Biology, Concordia University, Montréal, QC, Canada.
Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH